All Stories

  1. Social and Emotional Loneliness in Older Community Dwelling-Individuals: The Role of Socio-Demographics
  2. Foot Orthosis and Sensorized House Slipper by 3D Printing
  3. Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer
  4. Circadian Rhythm and Concentration of Melatonin in Breast Cancer Patients
  5. Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review
  6. Lymphocytes as a Biomarker of Frailty Syndrome: A Scoping Review
  7. Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
  8. Special Issue “Mental Health Issues and Quality of Life in Older Individuals”
  9. Hair Cortisol Concentration as a Biomarker of Sleep Quality and Related Disorders
  10. Effects of Probiotics in the Management of Infected Chronic Wounds: From Cell Culture to Human Studies
  11. New Effects of Prebiotics, Probiotics, and Symbiotics
  12. Salivary Stress/Immunological Markers in Crohn’s Disease and Ulcerative Colitis
  13. Immune Alterations in Frailty Syndrome and Cognitive Impairment
  14. Neurotransmitters and Behavioral Alterations Induced by Nickel Exposure
  15. Mechanical Plantar Foot Stimulation in Parkinson′s Disease: A Scoping Review
  16. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects
  17. Therapeutic Plasmapheresis with Albumin Replacement in Alzheimer’s Disease and Chronic Progressive Multiple Sclerosis: A Review
  18. Peripheral Oxidative Stress Markers in Patients with Bipolar Disorder during Euthymia and in Siblings
  19. Neuro-Psychiatric Alterations in Patients with Diabetic Foot Syndrome
  20. Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies
  21. Alcohol and Cannabis Intake in Nursing Students
  22. Neuro-Psychiatric Disorders: From Diagnosis to Care
  23. Quality of Life in People with Coeliac Disease: Psychological and Socio- Economic Aspects
  24. Homocysteine Levels in Autism Spectrum Disorder: A Clinical Update
  25. Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders
  26. Editorial: Metabolic and Hormonal Alterations in Neuro-Psychiatric Disorders
  27. A survey on sleep assessment methods
  28. A survey on sleep questionnaires and diaries
  29. Blood Infusion and the Risk of Haemorrhage in Patients Undergoing Cardiac Surgery with Extracorporeal Circulation
  30. Research in Medical–Surgical Nursing
  31. Sleep Alterations in Non-demented Older Individuals: The Role of Cortisol
  32. Relationship between adipic acid concentration and the core symptoms of autism spectrum disorders
  33. Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital
  34. Lead Excretion in Spanish Children with Autism Spectrum Disorder
  35. Multiparametric magnetic resonance in the assessment of the gender differences in a high-grade glioma rat model
  36. Interleukin 6 and cognitive dysfunction
  37. Gender differences in Neurotoxicity
  38. Behavioral deficits induced by lead exposure are accompanied by serotonergic and cholinergic alterations in the prefrontal cortex
  39. Alteration of serotonin system by polychlorinated biphenyls exposure
  40. Alterations of apparent diffusion coefficient (ADC) in the brain of rats chronically exposed to lead acetate
  41. Motor alterations induced by chronic lead exposure
  42. Hyperammonemia Increases GABAergic Tone in the Cerebellum but Decreases It in the Rat Cortex
  43. Role of NMDA receptors in acute liver failure and ammonia toxicity: Therapeutical implications
  44. Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats
  45. Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts
  46. Sensitization to caffeine and cross-sensitization to amphetamine: Influence of individual response to caffeine
  47. Mechanisms of developmental neurotoxicity: Molecular and behavioral correlates
  48. Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function
  49. Modulation of NMDA receptors in the cerebellum. 1. Properties of the NMDA receptor that modulate its function
  50. Caffeine and the dopaminergic system
  51. Subchronic Caffeine Exposure Induces Sensitization to Caffeine and Cross-Sensitization to Amphetamine Ipsilateral Turning Behavior Independent from Dopamine Release
  52. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D 1 and D 2 receptor agonists
  53. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors